Articular Cartilage: Where it all started
The progenitor cells that form articular cartilage express a gene for a protein called NFATc1, which stops articular chondrocytes from developing too early in the joint.
- The First Affiliated Hospital of Xiamen University‐ICMRS Collaborating Center for Skeletal Stem Cell, State Key Laboratory of Cellular Stress Biology, Faculty of Medicine and Life Sciences, Xiamen University, China
- Fujian Provincial Key Laboratory of Organ and Tissue Regeneration, School of Medicine, Xiamen University, China
Articular cartilage is a smooth white tissue that covers the ends of bones where they join together. It is essential for maintaining the mobility of bone joints. However, despite this important role, the tissue is susceptible to degeneration caused by trauma, disease or ageing. This can lead to conditions such as osteoarthritis, which can cause chronic pain and, in some cases, disability (Cui et al., 2020).
Reversing damage to articular cartilage remains a great challenge in musculoskeletal medicine. One way to tackle this issue is to better understand how articular cartilage forms during embryonic development, as this knowledge could help researchers to develop new methods for rebuilding cartilage. Yet, the origins of the main cells in cartilage, known as articular chondrocytes, and the identity of the genes that regulate their production remain unclear. Now, in eLife, Xianpeng Ge (Capital Medical University in Beijing) and colleagues – including Fan Zhang and Yuanyuan Wang as joint first authors – report new insights into the formation of articular chondrocytes (Zhang et al., 2023).
Previous research has shown that the gene NFATc1 helps to regulate the development of bones by controlling cells that absorb and form bone (Winslow et al., 2006). To find out if NFATc1 could also be involved in cartilage development, Zhang et al. used genetically modified mouse embryos, in which cells expressing NFATc1 were tagged with a fluorescent marker that allowed the researchers to track these cells and their offspring over time. This revealed that NFATc1 is expressed in a group of progenitor cells throughout embryonic and even postnatal development, and that these cells are responsible for generating most of the articular chondrocytes (Figure 1).
Figure 1
The role of NFATc1 in articular cartilage formation.
Zhang et al. identified a unique progenitor cell population in the knee joint of embryonic mice (left) that expresses a gene called NFATc1, which has previously been linked to bone formation and bone resorption. These progenitor (stem) cells are responsible for generating articular chondrocytes – the main cell type in articular cartilage – during both embryonic and postnatal development (right). Suppressing the activity of NFATc1 in these stem progenitor cells induces the formation of chondrocytes, which are essential for forming articular cartilage.
Further experiments in cells and embryonic mice revealed that the expression of NFATc1 decreased as the articular chondrocytes matured. Zhang et al. found that when the gene was removed from the cartilage progenitors, the maturation of chondrocytes was faster and the formation of articular cartilage in embryos was still supported. Consistent with this, when NFATc1 was overactivated, the progenitor cells could no longer mature into chondrocytes. This indicates that this gene negatively regulates the development of articular chondrocytes.
So far, it has been challenging to track how articular cartilage develops as most genetic markers cannot distinguish between the different cell types in the relevant tissues (Rux et al., 2019; Chijimatsu and Saito, 2019). The only exception is the gene Prg4, a widely used marker of articular cartilage progenitors. But since cells only start to express this gene at a later stage during development, the marker fails to track their movement during the earlier stages (Kozhemyakina et al., 2015). In contrast, NFATc1 is expressed early during articular cartilage development, and may therefore offer a better alternative for studying the origin of articular cartilage.
It was previously thought that NFATc1, together with another gene involved in cartilage formation, NFATc2, restricts the overgrowth of cartilage (also known as osteochondroma) at the sites where the ligaments insert into the bone. However, adjusting how much of either of those genes was removed from the mice’s progenitor cells could in fact determine the number and size of osteochondromas (Ge et al., 2016). This knowledge may be helpful in understanding how NFATc1 may suppress the formation of cartilage in certain diseases.
It has been suggested that both NFATc1 and NFATc2 are key suppressors of osteoarthritis, which is crucial for articular cartilage formation in mice (Greenblatt et al., 2013). However, when Zhang et al. used a different approach to delete these two genes, they observed the opposite effect – removing NFATc1 and NFATc2 enhanced chondrogenesis under pathological conditions. This suggests that researchers should carefully consider the genetic ablating tools they use when studying the role of progenitor cells in articular cartilage.
Moreover, it has been shown that adult skeletal stem cells expressing NFATc1 behave as bone-cell progenitors and contribute to the early stages of repair following a bone fracture (Yu et al., 2022). This highlights the complex pool of progenitor cells that express NFATc1, and how the fate of these progenitors changes during different periods of development as well as adulthood. More importantly, to date, it remains unclear whether these NFATc1-expressing progenitor cells fulfill stemness criteria in the skeleton, such as stem-cell transplantation (Debnath et al., 2018), or if these cells are able to generate functional articular cartilage.
Despite a lack of evidence confirming the stemness of NFATc1-expressing progenitor cells, the work of Zhang et al. offers researchers an additional genetic tool to detect and track the origins of articular chondrocytes. Moreover, their findings provide valuable insights into the mechanism of articular cartilage formation. If studies in human cells achieve similar results, this may help scientists to identify potential treatments of cartilage diseases, such as osteoarthritis.
References
-
Mechanisms of synovial joint and articular cartilage developmentCellular and Molecular Life Sciences 76:3939–3952.https://doi.org/10.1007/s00018-019-03191-5
-
Identification of a Prg4-expressing articular cartilage progenitor cell population in miceArthritis & Rheumatology 67:1261–1273.https://doi.org/10.1002/art.39030
-
Joints in the appendicular skeleton: developmental mechanisms and evolutionary influencesCurrent Topics in Developmental Biology 133:119–151.https://doi.org/10.1016/bs.ctdb.2018.11.002
-
Calcineurin/NFAT signaling in osteoblasts regulates bone massDevelopmental Cell 10:771–782.https://doi.org/10.1016/j.devcel.2006.04.006
Article and author information
Author details
Publication history
- Version of Record published: April 5, 2023 (version 1)
Copyright
© 2023, Zhang et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 524
- views
-
- 60
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Articular Cartilage: Where it all started
eLife 12:e87355.
https://doi.org/10.7554/eLife.87355
Further reading
-
- Medicine
There is clear evidence that the sympathetic nervous system (SNS) mediates bone metabolism. Histological studies show abundant SNS innervation of the periosteum and bone marrow-these nerves consist of noradrenergic fibers that immunostain for tyrosine hydroxylase, dopamine beta hydroxylase, or neuropeptide Y. Nonetheless, the brain sites that send efferent SNS outflow to bone have not yet been characterized. Using pseudorabies (PRV) viral transneuronal tracing, we report, for the first time, the identification of central SNS outflow sites that innervate bone. We find that the central SNS outflow to bone originates from 87 brain nuclei, sub-nuclei and regions of six brain divisions, namely the midbrain and pons, hypothalamus, hindbrain medulla, forebrain, cerebral cortex, and thalamus. We also find that certain sites, such as the raphe magnus (RMg) of the medulla and periaqueductal gray (PAG) of the midbrain, display greater degrees of PRV152 infection, suggesting that there is considerable site-specific variation in the levels of central SNS outflow to bone. This comprehensive compendium illustrating the central coding and control of SNS efferent signals to bone should allow for a greater understanding of the neural regulation of bone metabolism, and importantly and of clinical relevance, mechanisms for central bone pain.
-
- Computational and Systems Biology
- Medicine
Background:
Preterm birth is the leading cause of neonatal morbidity and mortality worldwide. Most cases of preterm birth occur spontaneously and result from preterm labor with intact (spontaneous preterm labor [sPTL]) or ruptured (preterm prelabor rupture of membranes [PPROM]) membranes. The prediction of spontaneous preterm birth (sPTB) remains underpowered due to its syndromic nature and the dearth of independent analyses of the vaginal host immune response. Thus, we conducted the largest longitudinal investigation targeting vaginal immune mediators, referred to herein as the immunoproteome, in a population at high risk for sPTB.
Methods:
Vaginal swabs were collected across gestation from pregnant women who ultimately underwent term birth, sPTL, or PPROM. Cytokines, chemokines, growth factors, and antimicrobial peptides in the samples were quantified via specific and sensitive immunoassays. Predictive models were constructed from immune mediator concentrations.
Results:
Throughout uncomplicated gestation, the vaginal immunoproteome harbors a cytokine network with a homeostatic profile. Yet, the vaginal immunoproteome is skewed toward a pro-inflammatory state in pregnant women who ultimately experience sPTL and PPROM. Such an inflammatory profile includes increased monocyte chemoattractants, cytokines indicative of macrophage and T-cell activation, and reduced antimicrobial proteins/peptides. The vaginal immunoproteome has improved predictive value over maternal characteristics alone for identifying women at risk for early (<34 weeks) sPTB.
Conclusions:
The vaginal immunoproteome undergoes homeostatic changes throughout gestation and deviations from this shift are associated with sPTB. Furthermore, the vaginal immunoproteome can be leveraged as a potential biomarker for early sPTB, a subset of sPTB associated with extremely adverse neonatal outcomes.
Funding:
This research was conducted by the Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS) under contract HHSN275201300006C. ALT, KRT, and NGL were supported by the Wayne State University Perinatal Initiative in Maternal, Perinatal and Child Health.
